These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16429832)

  • 1. [Evolution of manufacturing conditions and facilities in the pharmaceutical industry].
    Lhoest W
    J Pharm Belg; 2005; 60(4):109-16. PubMed ID: 16429832
    [No Abstract]   [Full Text] [Related]  

  • 2. Masters of efficiency.
    Hoag H
    Nat Biotechnol; 2007 Jan; 25(1):139-40. PubMed ID: 17211408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical benchmarks--2003.
    Walsh G
    Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
    [No Abstract]   [Full Text] [Related]  

  • 4. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report.
    Karanth H; Shenoy VS; Murthy RR
    AAPS PharmSciTech; 2006 Oct; 7(4):87. PubMed ID: 17233539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmaceutical engineering in drug formulation].
    Bruguera JL; Reynier JP; Rochat MH; Verain A
    J Pharm Belg; 1990; 45(4):274-9. PubMed ID: 2290123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
    Hippenmeier F
    Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
    [No Abstract]   [Full Text] [Related]  

  • 7. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry.
    Wallhäusser KH
    J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623
    [No Abstract]   [Full Text] [Related]  

  • 8. AUTOMATION OF DRAGEE PRODUCTION.
    RIECKMANN P
    Drugs Made Ger; 1963 Sep; 6():162-4. PubMed ID: 14060946
    [No Abstract]   [Full Text] [Related]  

  • 9. Air filtration systems and restrictive access conditions improve indoor air quality in clinical units: Penicillium as a general indicator of hospital indoor fungal levels.
    Araujo R; Cabral JP; Rodrigues AG
    Am J Infect Control; 2008 Mar; 36(2):129-34. PubMed ID: 18313515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New active agents. The composition of commercial pharmaceutical specialties in 2001].
    Bernard M
    J Pharm Belg; 2002; 57(1):1-13. PubMed ID: 11913094
    [No Abstract]   [Full Text] [Related]  

  • 11. Current and future issues in the manufacturing and development of monoclonal antibodies.
    Kozlowski S; Swann P
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):707-22. PubMed ID: 16828921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and operation of a new sterile manufacturing facility.
    Fornabaio TA
    Bull Parenter Drug Assoc; 1970; 24(3):110-8. PubMed ID: 5422900
    [No Abstract]   [Full Text] [Related]  

  • 13. Penicillin contamination of drugs: evaluation of test conditions by use of laminar flow.
    Elias W; Vellutato A
    Bull Parenter Drug Assoc; 1966; 20(6):193-8. PubMed ID: 5956957
    [No Abstract]   [Full Text] [Related]  

  • 14. Facility for small volume parenteral manufacturing.
    Kelly PC
    Bull Parenter Drug Assoc; 1976; 30(2):72-9. PubMed ID: 949564
    [No Abstract]   [Full Text] [Related]  

  • 15. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
    Schirlin D; Galvan M; Le Fur G
    Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicines for children: a matter of taste.
    Davies EH; Tuleu C
    J Pediatr; 2008 Nov; 153(5):599-604, 604.e1-2. PubMed ID: 18940350
    [No Abstract]   [Full Text] [Related]  

  • 17. [The "third party" in the pharmaceutical industry].
    Karrer E
    Boll Chim Farm; 1966 Aug; 105(8):563-9. PubMed ID: 6003361
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathological aspects in the pharmaceutical industry: diseases in the workers assigned to extraction and compounding of drugs].
    Nava C; Briatico-Vangosa G; Marchisio M; Arbosti G
    Med Lav; 1974; 65(3-4):118-27. PubMed ID: 4444680
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of globalization of drug manufacturing, production, and sourcing and challenges for American drug safety.
    Woo J; Wolfgang S; Batista H
    Clin Pharmacol Ther; 2008 Mar; 83(3):494-7. PubMed ID: 18253142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On macroeconomic characteristics of pharmaceutical generics and the potential for manufacturing and consumption under fuzzy conditions.
    Gascón F; de la Fuente D; Puente J; Lozano J
    Artif Intell Med; 2007 Nov; 41(3):223-35. PubMed ID: 17719212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.